Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance.
Study Design
- 연구 유형
- Randomized Controlled Trial
- 대상 집단
- general population
- 중재
- Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. None
- 대조군
- placebo
- 일차 결과
- pain
- 효과 방향
- Neutral
- 비뚤림 위험
- Moderate
Abstract
BACKGROUND: Beano, an over-the-counter oral solution of alpha-galactosidase, is used to prevent flatus and other gastrointestinal symptoms resulting from a high-fiber diet. The efficacy of this product, however, has not yet been adequately evaluated. METHODS: Nineteen subjects were randomized into two groups and fed test meals of meatless chili. At the first test meal, group 1 received eight drops of alpha-galactosidase solution and group 2 received eight drops of placebo. After the meal, subjects were asked to keep a careful record of gastrointestinal symptoms, including occurrences of intestinal gas passage, for the next 6 hours. One week later, an identical test meal was served to each study subject and the solutions were reversed. Again subjects recorded their symptoms for the next 6 hours. Data were analyzed by means of paired t tests. RESULTS: The number of flatulence events per hour was significantly less in the group treated with alpha-galactosidase than placebo over the 6-hour follow-up period (F = 2.87, P = .016). When the two groups were compared at each follow-up interval, this difference was statistically significant only for the 5th hour after ingesting the test meal (t = 2.19, P = .04). No differences between the two groups were found in the extent of bloating or pain following the meal. CONCLUSIONS: Oral alpha-galactosidase solution is efficacious, at least in some patients, for the prophylaxis of gastrointestinal intolerance of oligosaccharides.
Used In Evidence Reviews
Similar Papers
Molecular genetics and metabolism · 2005
Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.
The American journal of gastroenterology · 2018
Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.
Digestive diseases and sciences · 2007
The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms.
Clinical biochemistry · 2015
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene.
Scandinavian journal of gastroenterology · 2016
Does oral α-galactosidase relieve irritable bowel symptoms?
International journal of environmental research and public health · 2021